PHARMAQ Norway Transparency Act Statement 2022

This Statement describes the activities of Pharmaq AS and Pharmaq Analytiq
AS (collectively “Pharmaq Norway,” “we,” “us” and “our”) to address
fundamental human rights and decent working conditions in our business
and supply chain during the year ended December 31, 2022. This Statement
is published pursuant to the “Act relating to enterprises’ transparency and
work on fundamental human rights and decent working conditions” (the
“Transparency Act”).

Read more >